...BRCA2-mediated suppression of cell proliferation, indicating that MAGE-D1 is a downstream target of BRCA2 and that BRCA2...
...BRCA2 mutation carriers. Descriptive analyses were done followed by survival analyses and a Poisson regression analysis....
...BRCA2, which are associated with a major risk of breast cancer during lifetime, has improved the assessment of the indiv...
...BRCA2 mutation; BRCA2c.6287_6290del. We have shown that the founder mutation BRCA1 c.3171ins5 has a great influence on w...
...BRCA2 mutation and with no prior diagnosis of breast or ovarian cancer were identified through the records of two large ...
...BRCA2.,The percentage of first- and second-degree relatives tested for the BRCA-mutation was 36%. Uptake levels for pred...
...BRCA2 mutations have an increased risk of contralateral breast cancer and cancer of the ovary. Furthermore, recent resea...
...BRCA2 loss of heterozygosity (LOH) is found in almost all BRCA1 and BRCA2 carcinomas, respectively. Furthermore, all typ...
...BRCA2. EMSY contains an approximately 100-residue segment at the amino terminus called the ENT (EMSY N-terminal) domain....
...BRCA2 mutation identified are commonly suggested to consider ovarian carcinoma screening with transvaginal ultrasound an...
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
